MedTrace Logo

Point-of-care Lung Ultrasound (POCUS)-Integrated Study of Admitted Patients With COVID-19

NCT05228717 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2022-04-29

No results posted yet for this study

Summary

This study seeks to define the ultrasound profile of patients with COVID-19, and document the progression of these ultrasound findings to develop prognostication and clinical decision instruments that can help guide management of patient with COVID-19. Primary aims include the development of ARDS, refractory hypoxemia, acute cardiac injury, pulmonary embolism, pneumothorax or death. Secondary aims include potential change in CT and plain film utilization given the use of POCUS, as well as emergency department and inpatient LOS (length of stay).

Conditions

  • Lung Injury
  • ARDS
  • Acute Cardiac Event
  • Covid19
  • Ultrasound
  • Hypoxemia
  • Acute Respiratory Distress Syndrome

Interventions

DIAGNOSTIC_TEST

Point of Care Ultrasound

q48-72h point of care ultrasound of the lungs, heart, and IVC (inferior vena cava)

Sponsors & Collaborators

  • Olive View-UCLA Education & Research Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-10
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05228717 on ClinicalTrials.gov